Rosuvastatin patient counseling information: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Rosuvastatin}} {{CMG}}; {{AE}} {{SS}} ==Patient Counseling Information== ===Skeletal Muscle Effects=== Patients should be advised to report promptly unexplained...")
 
m (Protected "Rosuvastatin patient counseling information": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Rosuvastatin#Patient Counseling Information]]
{{Rosuvastatin}}
{{CMG}}; {{AE}} {{SS}}


==Patient Counseling Information==
[[Category: Cardiovascular Drugs]]
 
[[Category: Drug]]
===Skeletal Muscle Effects===
[[Category: Statins]]
 
Patients should be advised to report promptly unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever or if these muscle signs or symptoms persist after discontinuing CRESTOR.
 
===Concomitant Use of Antacids===
 
When taking CRESTOR with an aluminum and magnesium hydroxide combination antacid, the antacid should be taken at least 2 hours after CRESTOR administration.
 
===Pregnancy===
 
If the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus and the lack of known clinical benefit with continued use during pregnancy.
 
===Liver Enzymes ===
It is recommended that liver enzyme tests be performed before the initiation of CRESTOR and if signs or symptoms of liver injury occur. All patients treated with CRESTOR should be advised to promptly report any symptoms that may indicate liver injury, including fatigue, anorexia, right upper abdominal discomfort, dark urine or jaundice.
CRESTOR is a trademark of the AstraZeneca group of companies.
© AstraZeneca 2013
Licensed from SHIONOGI & CO., LTD., Osaka, Japan
Distributed by:
AstraZeneca Pharmaceuticals LP
Wilmington, DE 19850
ASTRAZENECA
Rev. August, 2013<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = CRESTOR (ROSUVASTATIN CALCIUM) TABLET, FILM COATED [ASTRAZENECA PHARMACEUTICALS LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb0f3b5e-4bc6-41c9-66b9-6257e2513512 | publisher =  | date =  | accessdate = 17 February 2014 }}</ref>
 
==References==
{{Reflist|2}}
 
{{Statins}}
 
[[Category:Statins]]
[[Category:AstraZeneca]]
[[Category:Carboxylic acids]]
[[Category:Sulfonamides]]
[[Category:Pyrimidines]]
[[Category:Organofluorides]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 17:07, 20 August 2015